Vestcor Inc’s Catalyst Pharmaceutical CPRX Stock Holding History

Vestcor Inc’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$834K	Buy	33,670 +10,190	+43%	+$243K	0.02%	554
2025 Q4	$548K	Sell	23,480 -33,107	-59%	-$737K	0.02%	679
2025 Q3	$1.11M	Sell	56,587 -5,060	-8%	-$104K	0.03%	446
2025 Q2	$1.34M	Buy	61,647 +32,942	+115%	+$778K	0.04%	407
2025 Q1	$696K	Buy	28,705 +840	+3%	+$18.9K	0.02%	563
2024 Q4	$582K	Sell	27,865 -32,566	-54%	-$700K	0.02%	621
2024 Q3	$1.2M	Buy	60,431 +9,379	+18%	+$174K	0.04%	424
2024 Q2	$791K	Buy	51,052 +25,121	+97%	+$391K	0.03%	497
2024 Q1	$413K	Sell	25,931 -32,937	-56%	-$496K	0.01%	719
2023 Q4	$990K	Sell	58,868 -747	-1%	-$10.2K	0.03%	447
2023 Q3	$697K	Buy	59,615 +7,942	+15%	+$106K	0.03%	518
2023 Q2	$694K	Buy	51,673 +6,759	+15%	+$97.3K	0.03%	523
2023 Q1	$745K	Hold	44,914	–	–	0.03%	526
2022 Q4	$835K	Buy	44,914 +9,887	+28%	+$152K	0.03%	517
2022 Q3	$449K	Hold	35,027	–	–	0.02%	705
2022 Q2	$246K	Buy	+35,027	New	+$257K	0.01%	857

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vestcor Inc's CPRX Position: Q1 2026 in Review

Vestcor Inc increased its Catalyst Pharmaceutical (CPRX) stake by 43% in Q1 2026, buying an estimated $243K and bringing the position to 33,670 shares worth $834K. The position accounts for 0.02% of the portfolio, ranked #554.

Vestcor Inc first reported a position in CPRX in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.34M in Q2 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Vestcor Inc held 33,670 shares of Catalyst Pharmaceutical worth $834K as of Q1 2026.
Vestcor Inc bought 10,190 Catalyst Pharmaceutical shares in Q1 2026, an estimated $243K.
Catalyst Pharmaceutical made up 0.02% of Vestcor Inc's portfolio in Q1 2026, its #554 holding.
Vestcor Inc first reported a position in Catalyst Pharmaceutical in Q2 2022 and has held it in 16 quarters since.
Vestcor Inc's Catalyst Pharmaceutical position peaked at $1.34M in Q2 2025.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.